» Articles » PMID: 24831052

Serogroup W Meningococcal Disease: Global Spread and Current Affect on the Southern Cone in Latin America

Overview
Date 2014 May 17
PMID 24831052
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Meningococcal serogroup W strains have been emerging throughout the current century with most of the isolates belonging to the sequence type (ST11)/electrophoretic type (ET37) clonal complex (ST11/E37 CC), particularly since the international outbreak following Hajj 2000. That outbreak appears to have triggered off that trend, contributing to the spread of W ST11/ET37 CC strains globally; however, local strains could be also responsible for increases in the percentage and/or incidence rates of this serogroup in some countries. More recently, unexpected increases in the percentage and incidence rate of W has been noticed in different countries located in the South Cone in Latin America, and W ST11/ET37 CC strains now appear as endemic in the region and an extensive immunization programme with tetravalent conjugate vaccine (covering serogroups A, C, Y and W) has been recently implemented in Chile. It is difficult to ascertain whether we are observing the emergence of W ST11 CC strains in different geographical areas or whether the Hajj 2000 strain is still spreading globally. Several aspects of the evolution of that situation are analysed in this paper, reviewing also the implications in immunization programmes. Closely related with the analysis of this potential evolution, it will be very interesting to monitor the evolution of serogroup W in the African meningitis belt after implementation of the extensive immunization programme with serogroup A conjugate vaccine that is currently underway. More data about carriers, transmission, clonal lineages, etc. are needed for taking decisions (target groups, outbreak control, defining the extent, etc.) to adapt the response strategy with potential interventions with broad coverage vaccines against the emergent serogroup W.

Citing Articles

Genomic Surveillance of Invasive Meningococcal Disease During a National MenW Outbreak in Australia, 2017-2018.

Sotheran E, Lane C, Horan K, Stevens K, Guglielmino C, Bradbury S Open Forum Infect Dis. 2024; 11(6):ofae249.

PMID: 38854393 PMC: 11161896. DOI: 10.1093/ofid/ofae249.


Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017.

Nuttens C, Findlow J, Balmer P, Swerdlow D, Htar M Euro Surveill. 2022; 27(3).

PMID: 35057902 PMC: 8804660. DOI: 10.2807/1560-7917.ES.2022.27.3.2002075.


Genomic surveillance of Neisseria meningitidis serogroup W in Portugal from 2003 to 2019.

Bettencourt C, Nunes A, Gomes J, Simoes M Eur J Clin Microbiol Infect Dis. 2021; 41(2):289-298.

PMID: 34787749 DOI: 10.1007/s10096-021-04371-7.


Development and Immunogenicity of a Brazilian Glycoconjugate vaccine against Meningococcal W in a Pilot Scale.

de Souza I, da Silva M, Bastos R, Pereira D, Figueira E, Jessouroun E Glycoconj J. 2021; 38(5):539-549.

PMID: 34515909 DOI: 10.1007/s10719-021-10016-w.


A Narrative Review of the W, X, Y, E, and NG of Meningococcal Disease: Emerging Capsular Groups, Pathotypes, and Global Control.

Tzeng Y, Stephens D Microorganisms. 2021; 9(3).

PMID: 33802567 PMC: 7999845. DOI: 10.3390/microorganisms9030519.


References
1.
Safadi M, Gonzalez-Ayala S, Jakel A, Wieffer H, Moreno C, Vyse A . The epidemiology of meningococcal disease in Latin America 1945-2010: an unpredictable and changing landscape. Epidemiol Infect. 2012; 141(3):447-58. PMC: 3566594. DOI: 10.1017/S0950268812001689. View

2.
Popovic T, Sacchi C, Reeves M, Whitney A, Mayer L, Noble C . Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex. Emerg Infect Dis. 2000; 6(4):428-9. PMC: 2640905. DOI: 10.3201/eid0604.000423. View

3.
Ferreira E, Dias R, Giorgini D, Canica M, Taha M . Neisseria meningitidis serogroup W135 in Portugal: presence of the ST-11/ET-37 clonal complex. Pathol Biol (Paris). 2008; 56(2):94-6. DOI: 10.1016/j.patbio.2007.10.005. View

4.
Taha M, Giorgini D, Ducos-Galand M, Alonso J . Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000. J Clin Microbiol. 2004; 42(9):4158-63. PMC: 516311. DOI: 10.1128/JCM.42.9.4158-4163.2004. View

5.
Hahne S, Gray S, Aguilera , Crowcroft N, Nichols T, Kaczmarski E . W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001. Lancet. 2002; 359(9306):582-3. DOI: 10.1016/s0140-6736(02)07716-4. View